Advanced genomic diagnostics can help pinpoint targeted cancer treatments with more accuracy than ever.
As well, a range of high-tech treatments (such as Proton Beam Therapy), opens up new possibilities for Pancreatic Cancer Patients.
The Grace Gawler Institute, working closely with its national and international oncology colleagues, clinics and networks, helps patients source state-of-the-art treatments in Australia or overseas.
UK patients - The Institute is also well-positioned to help UK patients with pancreatic cancer via state-of-the-art treatments in Europe - visit UK page here
The link below explains how our global cancer navigation service and precision medicine model is disrupting outdated, unwieldy, hospital approaches to Cancer.
So that you are better acquainted with all our new paradigm cancer services, please carefully read our website front page and associated links.
Welcome: I'm Grace Gawler, cancer navigator and patient advocate.
I've worked with cancer patients for 43 -yrs. In Nov 2017, I am able to help pancreatic cancer patients access the best of precision medicine.
This standard of precision medicine are not usually available in countries like Australia, Canada, New Zealand, and the UK.
With genomic screening and diagnostic tests able to pinpoint targeted treatments with higher probabilities of success, and, with high-tech treatments such as proton Beam therapy, and others, this once difficult to treat disease is no longer a death sentence.
Via my global medical alliance of innovative cancer specialists, we can provide a range of exceptional new treatments for pancreatic cancer patients; treatments not usually available in the patients home country.